Noveris Health Sciences is trading at CA$0.06, down 15.38%, as broader risk-off sentiment may be contributing.
- No company-specific announcement dated October 22 was found; Noveris’s news page lists its latest release as the September 9 annual and special meeting results.
- Reuters reported technology shares and major indexes fell amid renewed AI-spending concerns and rising oil prices.
- No trading-volume information was available in the provided data.